Clinical Outcomes of Follicular Thyroid Carcinoma Did Not Significantly Differ according to Tumor Size in an Iodine-Excessive Country
DM, R/SP, CSD, and TERT promoter mutations were not uncommon in FTCs <2 cm compared to those in larger FTCs, whereas FTCs ≥6 cm showed a sharp decline in prognosis, although this was statistically insignificant.
Authors
- Young Lyun Oh (ORCID: https://orcid.org/0000-0002-9127-4642)
- Yun Jae Chung (ORCID: https://orcid.org/0000-0002-2091-9554)
- Ji Hyun Yoo (ORCID: https://orcid.org/0000-0003-1057-8036)
- Tae Hyuk Kim (ORCID: https://orcid.org/0000-0002-7975-2437)
- Da Eun Leem
- Beom Joon Kim (ORCID: https://orcid.org/0000-0002-2719-3012)
- Jung Sun Kim (ORCID: https://orcid.org/0000-0002-7513-4500)
- Sun Wook Kim (ORCID: https://orcid.org/0000-0002-6858-3439)
- Jae Hoon Chung (ORCID: https://orcid.org/0000-0002-9563-5046)
Institutions
- Samsung Medical Center (KR)
- Chung-Ang University Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Endocrinology and Metabolism
- Published
- 2025-05-26
- DOI
- https://doi.org/10.3803/enm.2025.2324
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00